Max R. Wursta
- Indexed articles, last 90 days
- 11
- Latest publication
- Sep 25, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
PRP for lateral epicondylitis may not relieve pain, improve function vs. placebo (opens the original)
Read excerpt
VANCOUVER, British Columbia — According to results from a systematic review and meta-analysis, platelet-rich plasma was not associated with pain relief or functional improvements in patients with lateral epicondylitis vs. placebo. “PRP has been proposed as an option for noninvasive treatment for lateral epicondylitis. However, despite numerous studies, the results are heterogeneous, and the quality of evidence is often questionable,” Ramon Sampaio Souza Santos, MD, from the Center for Sports Tra
AI-based MRI, cartilage segmentation predicts knee surgery âat least as wellâ as humans (opens the original)
Read excerpt
Fully automated, AI-based cartilage segmentation with MRI identified knees requiring replacement with the same degree of success as manual human analysis, according to published results. “For cartilage morphometry to become a scalable and useful endpoint in clinical trials of disease-modifying (structure-modifying) interventions, image analysis should ideally be performed automatically and objectively, without human intervention,” Felix Eckstein, MD, from the center for anatomy and cell biology
Nearly 60% of US adults with arthritis report moderate to severe joint pain (opens the original)
Read excerpt
An estimated 58.5% of U.S. adults with arthritis have moderate to severe joint pain, a prevalence that surpasses the Healthy People 2030 goal of 52.4%, according to an analysis of National Health Interview Survey data from 2019 and 2023. “Severe joint pain is associated with reporting fair or poor health status, lower quality of life, disability, serious psychological distress and prescriptions for pain medications, including opioids,” Elizabeth A. Fallon, PhD, DrPH, and colleagues wrote in Arth
Low hydroxychloroquine intake, blood levels increase cardiovascular risk in lupus (opens the original)
Read excerpt
Patients with systemic lupus erythematosus and sustained low hydroxychloroquine blood levels may be at significantly increased risk for atherosclerotic cardiovascular disease, according to data published in Arthritis Care & Research. “Hydroxychloroquine (HCQ) is the cornerstone of SLE management because it reduces disease activity, prevents flares, limits organ damage accrual and has been associated with cardiovascular protection,” Shivani Garg, MD, PhD, director of the Yale Lupus Program, told
American College of Rheumatology president: Grant changes would have âchilling effectâ (opens the original)
Read excerpt
The American College of Rheumatology has issued formal comment to the U.S. Office of Management and Budget expressing âdeep concernâ with proposed changes to federal grant regulations and the grantmaking process. In a press release, the ACR said the proposed changes âwould harm the competitiveness of the U.S. research enterprise and the nationâs ability to advance scientific discovery and public health, while wasting taxpayer resources.â In addition, the changes would allow âarbitrar
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.